Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

NCT04305756 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Thromboembolism
Postpartum DVT
Thrombosis

Interventions

DRUG: Enoxaparin

Sponsor

University of Utah